These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8260566)

  • 1. On dopaminergic modulation of temporal information processing.
    Rammsayer TH
    Biol Psychol; 1993 Sep; 36(3):209-22. PubMed ID: 8260566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans?
    Rammsayer TH
    Neuropsychobiology; 1997; 35(1):36-45. PubMed ID: 9018022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remoxipride versus haloperidol in healthy volunteers: psychometric performance and subjective tolerance profiles.
    Rammsayer T; Gallhofer B
    Int Clin Psychopharmacol; 1995 Mar; 10(1):31-7. PubMed ID: 7622802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropharmacological evidence for different timing mechanisms in humans.
    Rammsayer TH
    Q J Exp Psychol B; 1999 Aug; 52(3):273-86. PubMed ID: 10467900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cognitive-neuroscience approach for elucidation of mechanisms underlying temporal information processing.
    Rammsayer TH
    Int J Neurosci; 1994 Jul; 77(1-2):61-76. PubMed ID: 7989162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.
    Lidow MS; Goldman-Rakic PS
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4353-6. PubMed ID: 8183912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
    Ogren SO; Rosén L; Fuxe K
    Neuroscience; 1994 Jul; 61(2):269-83. PubMed ID: 7969908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A; Gustafsson K; Andersson I
    Eur J Pharmacol; 1994 Dec; 288(1):89-95. PubMed ID: 7705472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys.
    Gerlach J; Casey DE
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):103-12. PubMed ID: 1967845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of noradrenergic activity on temporal information processing in humans.
    Rammsayer TH; Hennig J; Haag A; Lange N
    Q J Exp Psychol B; 2001 Aug; 54(3):247-58. PubMed ID: 11547514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.
    Franken IH; Nijs I; Pepplinkhuizen L
    Psychopharmacology (Berl); 2008 Jan; 195(4):537-46. PubMed ID: 17891382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
    Ogren SO; Lundström J; Nilsson LB; Widman M
    J Neural Transm Gen Sect; 1993; 93(3):187-203. PubMed ID: 8217058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of body core temperature and brain dopamine activity on timing processes in humans.
    Rammsayer TH
    Biol Psychol; 1997 Aug; 46(2):169-92. PubMed ID: 9288412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective dopamine D2 antagonist and prolactin response in acute schizophrenia--results from remoxipride studies. The Canadian Remoxipride Study Group.
    Awad AG; Lapierre YD; Jostell KG
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):769-77. PubMed ID: 2149882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of transient 40-Hz auditory response by haloperidol suggests modulation of human selective attention by dopamine D2 receptors.
    Ahveninen J; Kähkönen S; Tiitinen H; Pekkonen E; Huttunen J; Kaakkola S; Ilmoniemi RJ; Jääskeläinen IP
    Neurosci Lett; 2000 Sep; 292(1):29-32. PubMed ID: 10996442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
    Magnusson O; Fowler CJ; Mohringe B; Wijkström A; Ogren SO
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):379-84. PubMed ID: 2900472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
    Ogren SO; Hall H; Widman M; Angeby-Möller K
    Pharmacol Toxicol; 1993 Dec; 73(6):325-34. PubMed ID: 8153056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical findings with new antipsychotic agents: what makes them atypical?
    Jackson DM; Ryan C; Evenden J; Mohell N
    Acta Psychiatr Scand Suppl; 1994; 380():41-8. PubMed ID: 7914047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic properties of the internal clock underlying time perception in humans.
    Rammsayer TH; Vogel WH
    Neuropsychobiology; 1992; 26(1-2):71-80. PubMed ID: 1475040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.